Radiotherapy & Oncology
Volume 95, Issue 1 , Pages 60-65 , April 2010

Dose–volume histogram and dose–surface histogram analysis for skin reactions to carbon ion radiotherapy for bone and soft tissue sarcoma

Received 17 March 2009 ,Revised 24 August 2009 ,Accepted 27 August 2009.

References 

  1. Tsujii H, Morita S, Miyamoto T, et al. Preliminary results of phase I/II carbon ion therapy at National Institute of Radiological Sciences. J Brachyther Int. 1997;13:1–8
  2. Tsujii H, Morita S, Miyamoto T, et al. The current status and perspective of heavy-ion therapy. In: Proceedings of the sixth international meeting on progress in radio-oncology, Bologna, Monduzzi Editore S.p.A; 1998. p. 709–21.
  3. Kamada T, Tsujii H, Tsuji H, et al. Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcoma. J Clin Oncol. 2002;20:4466–4471
  4. Endo M, Koyama-Ito H, Tsujii H, et al. HIPLAN – a heavy ion treatment planning system at HIMAC. J Jpn Soc Ther Radiol Oncol. 1996;8:231–238
  5. International commission on radiation units and measurements. Prescribing, recording, and reporting photon beam therapy (supplement to ICRU Report 50). ICRU Report 62, Bethesda; 1999. p. 3–20.
  6. Kanai T, Endo M, Minohara S, et al. Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy. Int J Radiat Oncol Biol Phys. 1999;44:201–210
  7. Cox JD, Stetz BS, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys. 1995;31:1341–1346
  8. Hopewell JW. Mechanisms of the action of radiation on skin and underlying tissues. Br J Radiol (Suppl). 1986;19:39–51
  9. Bentzen SM, Saunders MI, Dische S, et al. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial. Radiother Oncol. 2001;60:123–135
  10. Fenwick JD, Khoo VS, Nahum AE, et al. Correlations between dose–surface histograms and the incidence of long-term rectal bleeding following conformal or conventional radiotherapy treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 2001;49:473–480
  11. Meijer GJ, van den Brink M, Hoogeman MS, et al. Dose–wall histograms and normalized dose–surface histograms for the rectum: a new method to analyze the dose distribution over the rectum in conformal radiotherapy. Int J Radiat Oncol Biol Phys. 1999;45:1073–1080
  12. Boersma LJ, van den Brink M, Bruce AM, et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70–78Gy) conformal radiotherapy for prostate cancer using dose–volume histograms. Int J Radiat Oncol Biol Phys. 1998;41:83–92
  13. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21:109–122
  14. Giro C, Berger B, Boelke E, et al. High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: results of a survey in EORTC institute. Radiother Oncol. 2009;90:166–171
  15. Stone RS, Larkin JC. Treatment of cancer with fast neutrons. Radiology. 1942;39:608–620
  16. Duncan W. An evaluation of the results of neutron therapy trials. Acta Oncol. 1994;33:299–306
  17. Hall EJ. Radiobiology for the radiologist. 4th ed.. Philadelphia: J.B. Lippincott; 1994;p. 157 and 217
  18. Lee N, Chuang C, Quivey JM, et al. Skin toxicity due to intensity-modulated radiotherapy for head-and-neck carcinoma. Int J Radiat Oncol Biol Phys. 2002;53:630–637
  19. Doerr W, Hendry JH. Consequential late effects in normal tissues. Radiother Oncol. 2001;61:223–231
  20. Bentzen SM, Overgaard M. Relationship between early and late normal-tissue injury after postmastectomy radiotherapy. Radiother Oncol. 1991;20:159–165

PII: S0167-8140(09)00493-9

doi: 10.1016/j.radonc.2009.08.041

Radiotherapy & Oncology
Volume 95, Issue 1 , Pages 60-65 , April 2010

Article Tools

* Image Usage & Resolution